IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,483,000 | -10.4% | 111,941 | +60.2% | 0.40% | 0.0% |
Q3 2016 | $1,656,000 | +63.0% | 69,890 | +98.3% | 0.40% | +111.8% |
Q2 2016 | $1,016,000 | +71.6% | 35,244 | +90.7% | 0.19% | +120.0% |
Q1 2016 | $592,000 | -82.0% | 18,483 | -82.2% | 0.08% | -72.9% |
Q4 2014 | $3,290,000 | +166.8% | 103,843 | +122.5% | 0.31% | +282.9% |
Q1 2014 | $1,233,000 | -36.7% | 46,667 | -39.7% | 0.08% | -10.9% |
Q4 2013 | $1,947,000 | -77.0% | 77,452 | -81.2% | 0.09% | -76.1% |
Q3 2013 | $8,450,000 | -24.5% | 412,806 | -26.4% | 0.38% | -18.1% |
Q2 2013 | $11,185,000 | – | 560,974 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |